A potential role for free fatty acids in the pathogenesis of preeclampsia

Journal of Hypertension

Volumn 27, Issue 6, 2009, Pages 1293-1302

  Robinson, Nicola J ^a   Minchell, Laura J ^a   Myers, Jenny E ^a   Hubel, Carl A ^b   Crocker, Ian P ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Endothelial cells; Nonesterified fatty acids; Preeclampsia; Pregnancy; Vascular endothelium

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; FAT DROPLET; FATTY ACID; LINOLEIC ACID; OLEIC ACID; OXIDOREDUCTASE; PALMITIC ACID;

APOPTOSIS; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; LIPID STORAGE; MATERNAL PLASMA; MITOCHONDRIAL MEMBRANE POTENTIAL; NICK END LABELING; OXIDATION REDUCTION POTENTIAL; PATHOGENESIS; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; STAINING; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 67649653813     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328329fbfe     Document Type: Article

References (33)

1. CESDI. Confidential Enquiry into stillbirths and deaths in infancy. 5th Annual Report. Maternal and Child Health Research Consortium. 1998.
2. Hibbard B, Milner D. Reports on confidential enquiries into maternal deaths: an audit of previous recommendations. Health Trends 1994; 26:26-28.
3. Lewis G. Why women die. Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1997-1999. Department of Health, London. 2001.
4. Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension 2005; 46:1243-1249.
5. Zammit VC, Whitworth JA, Brown MA. Preeclampsia: the effects of serum on endothelial cell prostacyclin, endothelin, and cell membrane integrity. Am J Obstet Gynecol 1996; 174:737-743.
6. Scalera F, Schlembach D, Beinder E. Production of vasoactive substances by human umbilical vein endothelial cells after incubation with serum from preeclamptic patients. Eur J Obstet Gynecol Reprod Biol 2001; 99:172-178.
7. Baker PN, Davidge ST, Roberts JM. Plasma from women with preeclampsia increases endothelial cell nitric oxide production. Hypertension 1995; 26:244-248.
8. Zhang Y, Gu Y, Li H, Lucas MJ, Wang Y. Increased endothelial monolayer permeability is induced by serum from women with preeclampsia but not by serum from women with normal pregnancy or that are not pregnant. Hypertens Pregnancy 2003; 22:99-108.
9. Lorentzen B, Endresen MJ, Hovig T, Haug E, Henriksen T. Sera from preeclamptic women increase the content of triglycerides and reduce the release of prostacyclin in cultured endothelial cells. Thromb Res 1991; 63:363-372.
10. Hayman R, Warren A, Brockelsby J, Johnson I, Baker P. Plasma from women with preeclampsia induces an in vitro alteration in the endothelium-dependent behaviour of myometrial resistance arteries. BJOG 2000; 107:108-115.
11. Ashworth JR, Warren AY, Johnson IR, Baker PN. Plasma from preeclamptic women and functional change in myometrial resistance arteries. Br J Obstet Gynaecol 1998; 105:459-461.
12. Myers JE, Hart S, Armstrong S, Mires GJ, Beynon R, Gaskell SJ, Baker PN. Evidence for multiple circulating factors in preeclampsia. Am J Obstet Gynecol 2007; 196:266.e1-266.e6.
13. Montelongo A, Lasuncion MA, Pallardo LF, Herrera E. Longitudinal study of plasma lipoproteinsand hormones during pregnancy in normal and diabetic women. Diabetes 1992; 41:1651-1659.
14. Fahraeus L, Larsson-Cohn U, Wallentin L. Plasma lipoproteins including high density lipoprotein subfractions during normal pregnancy. Obstet Gynecol 1985; 66:468-472.
15. Lorentzen B, Drevon CA, Endresen MJ, Henriksen T. Fatty acid pattern of esterified and free fatty acids in sera of women with normal and preeclamptic pregnancy. Br J Obstet Gynaecol 1995; 102:530-537.
16. Ware-Jauregui S, Sanchez SE, Zhang C, Laraburre G, King IB, Williams MA. Plasma lipid concentrations in preeclamptic and normotensive Peruvian women. Int J Gynaecol Obstet 1999; 67:147-155.
17. Hubel CA, McLaughlin MK, Evans RW, Hauth BA, Sims CJ, Roberts JM. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 h post partum. Am J Obstet Gynecol 1996; 174:975-982.
18. Cekmen MB, Erbagci AB, Balat A, Duman C, Maral H, Ergen K, et al. Plasma lipid and lipoprotein concentrations in pregnancy induced hypertension. Clin Biochem 2003; 36:575-578.
19. Patel A, Barzi F, Jamrozik K, Lam TH, Ueshima H, Whitlock G, Woodward M. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation 2004; 110:2678-2686.
20. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3:213-219.
21. Henry PD. Hyperlipidemic arterial dysfunction. Circulation 1990; 81:697-699.
22. Okon EB, Chung AW, Zhang H, Laher I, van Breemen C. Hyperglycemia and hyperlipidemia are associated with endothelial dysfunction during the development of type 2 diabetes. Can J Physiol Pharmacol 2007; 85:562-567.
23. Vigne JL, Murai JT, Arbogast BW, Jia W, Fisher SJ, Taylor RN. Elevated nonesterified fatty acid concentrations in severe preeclampsia shift the isoelectric characteristics of plasma albumin. J Clin Endocrinol Metab 1997; 82:3786-3792.
24. Endresen MJ, Tosti E, Heimli H, Lorentzen B, Henriksen T. Effects of free fatty acids found increased in women who develop preeclampsia on the ability of endothelial cells to produce prostacyclin, cGMP and inhibit platelet aggregation. Scand J Clin Lab Invest 1994; 54:549-557.
25. Endresen MJ, Lorentzen B, Henriksen T. Increased lipolytic activity and high ratio of free fatty acids to albumin in sera from women with preeclampsia leads to triglyceride accumulation in cultured endothelial cells. Am J Obstet Gynecol 1992; 167:440-447.
26. Hostmark AT. Serum fatty acid/albumin molar ratio and the risk of diseases. Med Hypotheses 1995; 44:539-541.
27. Shankar SS, Steinberg HO. FFAs: do they play a role in vascular disease in the insulin resistance syndrome? Curr Diab Rep 2005; 5:30-35.
28. Myers J, Mires G, Macleod M, Baker P. In preeclampsia, the circulating factors capable of altering in vitro endothelial function precede clinical disease. Hypertension 2005; 45:258-263.
29. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55-63.
30. Hufnagel B, Dworak M, Soufi M, Mester Z, Zhu Y, Schaefer JR, et al. Unsaturated fatty acids isolated from human lipoproteins activate protein phosphatase type 2Cbeta and induce apoptosis in endothelial cells. Atherosclerosis 2005; 180:245-254.
31. Davda RK, Stepniakowski KT, Lu G, Ullian ME, Goodfriend TL, Egan BM. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension 1995; 26:764-770.
32. Ciapaite J, van Bezu J, van Eikenhorst G, Bakker SJ, Teerlink T, Diamant M, et al. Palmitate and oleate have distinct effects on the inflammatory phenotype of human endothelial cells. Biochim Biophys Acta 2007; 1771:147-154.
33. Gryzunov YA, Koplik EV, Smolina NV, Kopaeva LB, Dobretsov GE, Sudakov KV. Conformational properties of serum albumin binding sites in rats with different behaviour in the open field test. Stress 2006; 9:53-60.